IRWD - Ironwood Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 51.59B
Enterprise Value 31.98B
Trailing P/E N/A
Forward P/E 123.79
PEG Ratio (5 yr expected) 1-2.15
Price/Sales (ttm)4.60
Price/Book (mrq)N/A
Enterprise Value/Revenue 35.72
Enterprise Value/EBITDA 6-18.04

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019


Profit Margin -86.22%
Operating Margin (ttm)-34.62%

Management Effectiveness

Return on Assets (ttm)-16.03%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)346.21M
Revenue Per Share (ttm)2.25
Quarterly Revenue Growth (yoy)-0.60%
Gross Profit (ttm)147.14M
EBITDA -109.67M
Net Income Avi to Common (ttm)-298.51M
Diluted EPS (ttm)-1.94
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)119.05M
Total Cash Per Share (mrq)0.76
Total Debt (mrq)498.08M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)1.70
Book Value Per Share (mrq)-1.52

Cash Flow Statement

Operating Cash Flow (ttm)-82.38M
Levered Free Cash Flow (ttm)-36.37M

Trading Information

Stock Price History

Beta (3Y Monthly) 2.41
52-Week Change 3-34.19%
S&P500 52-Week Change 38.40%
52 Week High 317.76
52 Week Low 37.60
50-Day Moving Average 310.85
200-Day Moving Average 310.95

Share Statistics

Avg Vol (3 month) 31.4M
Avg Vol (10 day) 31.3M
Shares Outstanding 5155.62M
Float 142.22M
% Held by Insiders 12.60%
% Held by Institutions 1100.33%
Shares Short (May 31, 2019) 416.84M
Short Ratio (May 31, 2019) 410.05
Short % of Float (May 31, 2019) 412.69%
Short % of Shares Outstanding (May 31, 2019) 410.82%
Shares Short (prior month Apr 30, 2019) 415.3M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 21000/1194
Last Split Date 3Apr 2, 2019